The PM will lay the foundation stone for the National Institute for One Health and inaugurate the Centre for Research, Management and Control of Haemoglobinopathies, in Nagpur on December 11, 2022.
The new institutes of medical excellence will help to improve the country’s health research in order to serve vulnerable populations. The Prime Minister laid the foundation stone for the National Institute for One Health in Nagpur and inaugurated the ICMR-Centre for Research, Management and Control of Haemoglobinopathies in Chandrapur.
As humans increasingly interact with both domestic and wild animals, and as climate change continues to influence human health, it is no longer possible to view human health in isolation. More than 1/2 of all infections that people get are spread by animals. National Institute for One Health in Nagpur is an imperative infrastructural milestone for India in this context.
The Institute will focus on increasing preparedness and laboratory capabilities for the identification of novel and unknown zoonotic agents. This institute, dedicated to will be equipped with a Bio Safety Level (BSL-IV) laboratory. Developing better control strategies for emerging zoonotic agents will be aided by this investigation.
The expected carrier frequency of Sickle Cell disease in certain tribal groups in the Vidarbha region of Central India is as high as 35%. The ICMR – Centre for Research, Management & Control of Haemoglobinopathies has been set-up to play a leading role in research on haemoglobinopathies and similar diseases in the country.
This is in response to the realization of this issue and the spread of similar diseases in the country
The state-of-the-art diagnostic and research facilities at the centre, including bio-banking and proteomics facilities, will enable India to conduct pathbreaking research on the disease.
This centre of medical excellence is dedicated to haemoglobinopathies, which are inherited disorders of haemoglobin that include β-thalassemia syndromes and sickle cell disease, amongst others.
Interventions undertaken by the center through community control programmes and translational research will benefit patients in the underserved region of Chandrapur and adjoining areas.
